Intense pulsed light for the treatment of Rosacea and Telangiectasias

References

• Marks R. Rosacea, flushing and perioral dermatitis. Rook A. Textbook of Dermatology. 4th. Mosby-Year Book: St. Louis, 1986:1851–1863.
   Google Scholar
• Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Derm. 1981;76:15–18.
   PubMed Web of Science ®Google Scholar
• Webster G. Rosacea: A Review [Internet]. Medscape Education Dermatology. [posted 2010 March 31]. Available from: http://cme.medscape.com/viewarticle/719063.
   Google Scholar
• Dirschka T, Tronnier H, Fölster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Derm. 2004;150:1136–1141.
   PubMed Web of Science ®Google Scholar
• Laquieze S, Czernielewski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Derm Treat. 2007;18:158–162.
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn V, and Gallo R. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975–980.
   PubMed Web of Science ®Google Scholar
• Van Duyn J. Lymphedema in face scars. South Med J. 1969;62:1149–1150.
   PubMed Web of Science ®Google Scholar
• Rice WG, Weiss SJ. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science. 1990;249:178–181.
   PubMed Web of Science ®Google Scholar
• West JB, Mathieu-Costello O. Stress failure of pulmonary capillaries: role in lung and heart disease. Lancet. 1992; 340:762–767.
   PubMed Web of Science ®Google Scholar
• Motley RJ, Barton S, Marks R. The significance of telangiectasia in rosacea. Acne and Related Disorders: An International Symposium. Wales: Martin Dunitz: Cardiff; 1989:339–344.
   Google Scholar
• Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, . Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998;134:679–683.
   PubMed Web of Science ®Google Scholar
• Neilson PG. A double blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63–65.
   PubMed Web of Science ®Google Scholar
• Maddin S. A comparison of topical azeleic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40:961–965.
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Thiboutot D, Shalita A. Photographic review of results from a clinical study comparing benzoyl peroxide 5% clindamycin 1% topical gel with vehicle in rosacea. Cutis. 2004;73(suppl 6):11–17.
   PubMed Web of Science ®Google Scholar
• Wereide K. Long term treatment of rosacea with oral tetracycline. Acta Derm Venereol. 1969;49:176–179.
   PubMed Web of Science ®Google Scholar
• Webster GF. Treatment of rosacea. Semin Cutan Med Surg. 2001; 20:207–208 .
   PubMed Web of Science ®Google Scholar
• DelRosso JQ. Systemic therapy for rosacea: Focus on oral antibiotic therapy and safety. Cutis. 2000;66:7–13.
   PubMedGoogle Scholar
• Van Vlem B, Vanholder R, De Paepe P, Vogelears D, Ringoir S. Immunomodulating effects of antibiotics. Infection. 1996; 24:275–279.
   PubMed Web of Science ®Google Scholar
• Ueyama Y, Misaki M, Ishihara Y, Matsumura T. Effects of antibiotics on polymorphonuclear leukocyte chemotaxis in vitro. Br J Oral Maxilofacial Surg. 1994;32:96–99.
   PubMed Web of Science ®Google Scholar
• Drug Treatments for Skin Disease Introduced in 2006. [Posted 2007 July 20]. Skin Therapy Letter. 2007;12(4).
   Google Scholar
• Clark MB. A Lingering Facial Rash [Internet]. Posted: 30 August 2002. Available from: http://www.medscape.com/viewarticle/440405.
   Google Scholar
• Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low dose oral isotretinoin in rosacea. Arch Dermatol. 1994;130:319–324.
   PubMedGoogle Scholar
• Vienne MP, Ochando N, Borrel MT, Gall Y, Lauze C, . Retinaldehyde alleviates rosacea. Dermatol. 1999;199 (Suppl 1):53–56.
   PubMedGoogle Scholar
• Carlin RB, Carlin CS. Topical vitamin C preparation reduces erythema of rosacea. Cosmetic Dermatol. 2001;Feb:35–38.
   Google Scholar
• Green D. Generalized Essential Telangiectasia [Internet]. [Updated 2009 October 30]. Available from: http://emedicine.medscape.com/article/1083313-overview.
   Google Scholar
• Nouri K, Alster T, Choudhary S, Lupton J, Ballard C, . Laser Treatment of Acquired and Congenital Vascular Lesions [Internet]. [Updated 2010 June 10]. Available from: http://emedicine.medscape.com/article/1120509-overview.
   Google Scholar
• Romagnolo S, Benedetto A. Rosacea in a New Light [Internet]. Le Jacq Communications, Inc.; 2005 [Posted 2005 March 4]. Available from: http://www.medscape.com/viewarticle/499712.
   Google Scholar
• Ruiz-Esparza J, Goldman MP, Fitzpatrick RE, Lowe NJ, Behr KL. Flashlamp-pumped dye laser treatment of telangiectasias. J Dermatol Surg Oncol. 1993;19:1000–1003.
   PubMedGoogle Scholar
• NaturalLight Operator's Manual. Focus Medical LCC. Bethel, CT.
   Google Scholar
• Dierickx CC, Casparian JK, Venugopalan V, Farinelli WA, Anderson RR. Thermal relaxation of port-wine stain vessels probe in vivo: The need for 1–10 millisecond laser pulse treatment. J Invest Dermatol. 1995;105:709–714.
   PubMed Web of Science ®Google Scholar
• Schroeter CA, Haaf-von Below S, Neumann HA. Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg. 2005;31(10):1285–1289.
   PubMed Web of Science ®Google Scholar
• Angermeier MC. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther. 1999;1(2):95–100.
   PubMedGoogle Scholar
• Raulin C, Weiss RA, Schoenermark MP. Treatment of essential telangiectasias with an intense pulsed light source (PhotoDerm VL). Dermatol Surg. 1997;23:941–946.
   PubMed Web of Science ®Google Scholar
• Taub AF. Treatment of rosacea with intense pulsed light. J Drugs Dermatol. 2003;2:254–259.
   PubMedGoogle Scholar
• Mark KA, Sparacio RM, Voigt A, . Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment. Dermatol Surg. 2003;29:600–604.
   PubMed Web of Science ®Google Scholar
• Acland KM, Barlow RJ. Lasers for the dermatologist. Br J Dermatol. 2000;143:244–255.
   PubMed Web of Science ®Google Scholar
• Abramovits W, Arrazola P, Gupta A. Light Emitting Diode-Based Therapy [Internet]. Le Jacq Communications, Inc.; 2005 [Posted 2005 March 17]. Available from: http://www.medscape.com/viewarticle/499713.
   Google Scholar
• Laughlin SA, Dudley DK. Lasertherapy in the management of rosacea. J Cutan Med Surg. 1998;2(suppl4):S4-24-29.
   Google Scholar
• Wilkin JK. Rosacea. pathophysiology and treatment: Editorial. Arch Dermatol. 1994;130:359–362.
   PubMed Web of Science ®Google Scholar
• Christian Raulin, Bärbel Greve, Hortensia Grema. IPL technology: A review. Lasers in Surgery and Medicine. 2003;32(2): 78–87.
   PubMed Web of Science ®Google Scholar
• Aaron F. Cohen, MD, Jeffrey D. Tiemstra. Diagnosis and Treatment of Rosacea. Journal of the American Board of Family Medicine Clinical Review. J Am Board Fam Med. 2002;15(3).
   Google Scholar